Skip to content
Screener

Foghorn Therapeutics FHTX Q3 2025 earnings

Reported November 5, 2025 · Before market open

Revenue$8.2MMiss by $1.3M
EPS-$0.25Beat by $0.06
Revenue estimate$9.5M
EPS estimate-$0.31

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$7.1M
EPS estimate-$0.22

FAQ

When did Foghorn Therapeutics report Q3 2025 earnings?
Foghorn Therapeutics (FHTX) reported Q3 2025 earnings on November 5, 2025 before market open.
What were Foghorn Therapeutics's Q3 2025 revenue and EPS?
Foghorn Therapeutics reported revenue of $8.2M and eps of $-0.25 for Q3 2025.
Did Foghorn Therapeutics beat estimates in Q3 2025?
Revenue missed the consensus estimate of $9.5M by $1.3M. EPS beat the consensus estimate of $-0.31 by $0.06.
How did Foghorn Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 4.4% from $7.8M a year earlier and eps grew 19.4% from $-0.31.
Where can I find Foghorn Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-049236) and the 10-Q periodic report (0001628280-25-049238) directly on SEC EDGAR. The filing index links above go to sec.gov.